May 2007:
May 31st:
Portland Orthopaedics To Receive First Shipment Of Outsourced Hip Replacements
read article >
May 31st:
HalcyGen To Target US$1b Drugs Market With Licenses From Mayne Pharma IPO to Raise $12.5m. Lead Drug In Phase III Trials In 2007
read article >
May 31st:
Cytopia Announces Formation Of Clinical Advisory Panel To Advance CYT997 Into Phase II Trials
read article >
May 31st:
ChemGenex Appoints Dr George Morstyn to Board of Directors
read article >
May 31st:
Brainz Posts Appendix 4E
read article >
May 30th:
Imugene Strengthens Patent Protection Key Porcine Adenoviral Delivery Vector Patent Granted in Europe
read article >
May 29th:
MEDEC To Acquire Singapore's ATOS To Form MEDEC-ATOS Group
read article >
May 29th:
HealthLinx Funds Search For Valuable New Proteins From Milk And Dairy Processing Streams
read article >
May 29th:
Dr Michael Ironside New Head of Chemistry at Biosignal
read article >
May 18th:
Rockeby To Present Rapid Bird Flu Test Research To Pasteur Institute
read article >
May 18th:
Portland Orthopaedics Resumes Control Of US Hip Distribution
read article >
May 18th:
HealthLinx – Science And Operations GM Appointed
read article >
May 18th:
University Study Confirms Biosignal Technology Is Effective Against Corrosion Causing Bacteria
read article >
May 15th:
Pharmaxis Announces First Patient Enrollment In Aridol COPD Trial
read article >
May 11th:
Genepharm Australasia Clarifies Speculation In Today's Australian Financial Review
read article >
May 11th:
Bone Medical Limited Posts Appendix 3B & Announces Options Placement
read article >
May 10th:
Progen Pharmaceuticals Commences Entitlements Offer
read article >
|
